Matches in SemOpenAlex for { <https://semopenalex.org/work/W1538966211> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1538966211 endingPage "E679" @default.
- W1538966211 startingPage "E679" @default.
- W1538966211 abstract "In 1997, two types of papillary renal cell carcinoma (pRCC) with a distinctively different prognosis and outcome were described 1. It is remarkable that this distinction has often not been made in studies evaluating the outcome of pRCC, despite the observations of two very different clinical subgroups as recently as 2012 2. Kim et al. made an effort to analyze the prognostic impact of pRCC type on venous tumour thrombi, adding important data to our understanding of this second most common RCC subtype. Generally, type I is associated with a lower grade and stage and a better prognosis, whereas type II is more common in younger patients and frequently associated with advanced stage and poorer outcome 1. Although the prevalence of type I pRCC is reported to be higher than type II, this may be biased by pathology studies primarily including tissue obtained at curative nephrectomy for lower stages. Interestingly, no type I thrombi were observed in the present study. In metastatic pRCC, a report on RCC subtype and cytokine therapy found 87.5% of pRCC to be of type II 3. This strongly suggests that type II progresses more commonly than type I. This appears to be reflected in the study conducted by Kim et al. in which all pRCC tumour thrombi were of type II. Despite small numbers and concerns of multivariate analyses in these settings, the association is compelling. Kim et al. provide information for a risk-adapted follow-up of these patients. This makes sense because drugs are becoming available that target pathways involved in pRCC, such as the mesenchymal-epithelial transition factor 4 pathway in type I and potentially MYC and fumarate hydratase in type II. Targeted therapy trials are ongoing, focusing not only on types of pRCC, but also on mutation activation status, which may eventually lead to improved outcomes for pRCC 5." @default.
- W1538966211 created "2016-06-24" @default.
- W1538966211 creator A5068678186 @default.
- W1538966211 date "2012-09-14" @default.
- W1538966211 modified "2023-09-30" @default.
- W1538966211 title "TYPE II PAPILLARY HISTOLOGY PREDICTS POOR OUTCOME IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS" @default.
- W1538966211 cites W1986634084 @default.
- W1538966211 cites W2030706042 @default.
- W1538966211 cites W2090621589 @default.
- W1538966211 cites W2111005353 @default.
- W1538966211 doi "https://doi.org/10.1111/j.1464-410x.2012.11510.x" @default.
- W1538966211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22973898" @default.
- W1538966211 hasPublicationYear "2012" @default.
- W1538966211 type Work @default.
- W1538966211 sameAs 1538966211 @default.
- W1538966211 citedByCount "1" @default.
- W1538966211 countsByYear W15389662112023 @default.
- W1538966211 crossrefType "journal-article" @default.
- W1538966211 hasAuthorship W1538966211A5068678186 @default.
- W1538966211 hasConcept C126322002 @default.
- W1538966211 hasConcept C141071460 @default.
- W1538966211 hasConcept C142724271 @default.
- W1538966211 hasConcept C143998085 @default.
- W1538966211 hasConcept C146357865 @default.
- W1538966211 hasConcept C151730666 @default.
- W1538966211 hasConcept C2776531350 @default.
- W1538966211 hasConcept C2777472916 @default.
- W1538966211 hasConcept C2780091579 @default.
- W1538966211 hasConcept C2780227381 @default.
- W1538966211 hasConcept C2781362458 @default.
- W1538966211 hasConcept C2910216633 @default.
- W1538966211 hasConcept C38180746 @default.
- W1538966211 hasConcept C71924100 @default.
- W1538966211 hasConcept C86803240 @default.
- W1538966211 hasConceptScore W1538966211C126322002 @default.
- W1538966211 hasConceptScore W1538966211C141071460 @default.
- W1538966211 hasConceptScore W1538966211C142724271 @default.
- W1538966211 hasConceptScore W1538966211C143998085 @default.
- W1538966211 hasConceptScore W1538966211C146357865 @default.
- W1538966211 hasConceptScore W1538966211C151730666 @default.
- W1538966211 hasConceptScore W1538966211C2776531350 @default.
- W1538966211 hasConceptScore W1538966211C2777472916 @default.
- W1538966211 hasConceptScore W1538966211C2780091579 @default.
- W1538966211 hasConceptScore W1538966211C2780227381 @default.
- W1538966211 hasConceptScore W1538966211C2781362458 @default.
- W1538966211 hasConceptScore W1538966211C2910216633 @default.
- W1538966211 hasConceptScore W1538966211C38180746 @default.
- W1538966211 hasConceptScore W1538966211C71924100 @default.
- W1538966211 hasConceptScore W1538966211C86803240 @default.
- W1538966211 hasIssue "11b" @default.
- W1538966211 hasLocation W15389662111 @default.
- W1538966211 hasLocation W15389662112 @default.
- W1538966211 hasOpenAccess W1538966211 @default.
- W1538966211 hasPrimaryLocation W15389662111 @default.
- W1538966211 hasRelatedWork W1999843079 @default.
- W1538966211 hasRelatedWork W2027543741 @default.
- W1538966211 hasRelatedWork W2348241247 @default.
- W1538966211 hasRelatedWork W2379074688 @default.
- W1538966211 hasRelatedWork W2381388533 @default.
- W1538966211 hasRelatedWork W2390750009 @default.
- W1538966211 hasRelatedWork W2589291461 @default.
- W1538966211 hasRelatedWork W2602731626 @default.
- W1538966211 hasRelatedWork W4220939633 @default.
- W1538966211 hasRelatedWork W4313224453 @default.
- W1538966211 hasVolume "110" @default.
- W1538966211 isParatext "false" @default.
- W1538966211 isRetracted "false" @default.
- W1538966211 magId "1538966211" @default.
- W1538966211 workType "article" @default.